Biocept DIO Ratio 2011-2026 | BIOC

Annual DIO Ratio Biocept

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
21.9	22.1	33	25.5	21.3	19.5	29	27.7	31.7	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
33	19.5	25.8

Quarterly DIO Ratio Biocept

2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
22.4	22	-	32.8	31.1	25.9	-	24	38.4	26.3	-	30.1	69.9	41.8	24.4	24.7	26.2	23.8	22	21.6	19.9	20.4	19.3	18.3	19.2	22.4	26.4	26.7	30	27.8	25	27.5	31.5	21.4	28	32	47.9	19.5	-	13.7	14.3	7.74	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
69.9	7.74	26.5

DIO Ratio of other stocks in the Diagnostics research industry

Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
Trinity Biotech plc TRIB	212	$ 0.65	-1.84 %	$ 61.9 M	Irlanda
Centogene N.V. CNTG	25.4	-	-6.23 %	$ 30.6 M	Germany
Agilent Technologies A	97.1	$ 115.55	1.0 %	$ 35.1 B	USA
Accelerate Diagnostics AXDX	198	-	-61.36 %	$ 2.46 M	USA
Aspira Women's Health AWH	32.2	-	-6.19 %	$ 10.5 M	USA
Chembio Diagnostics CEMI	97.6	-	0.22 %	$ 16.8 M	USA
Co-Diagnostics CODX	1.69 K	$ 1.67	-2.34 %	$ 2.22 M	USA
Castle Biosciences CSTL	48.7	$ 24.46	3.25 %	$ 679 M	USA
CareDx, Inc CDNA	48.3	$ 21.23	5.83 %	$ 1.13 B	USA
Oxford Immunotec Global PLC OXFD	210	-	-	$ 562 M	Britain
DermTech DMTK	33.5	-	-11.32 %	$ 2.94 M	USA
Lantheus Holdings LNTH	40.4	$ 84.33	1.82 %	$ 5.69 B	USA
Enzo Biochem ENZ	156	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	60.9	-	-	$ 19.8 B	USA
Fulgent Genetics FLGT	7.17	$ 16.31	1.75 %	$ 493 M	USA
Global Cord Blood Corporation CO	89.7	-	-	$ 399 M	China
Fluidigm Corporation FLDM	131	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	42.1	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	62.8	-	0.12 %	$ 80.1 M	China
Charles River Laboratories International CRL	35.3	$ 169.8	1.23 %	$ 8.42 B	USA
Guardant Health GH	82.1	$ 88.91	1.18 %	$ 11.1 B	USA
HTG Molecular Diagnostics HTGM	116	-	-20.0 %	$ 1.06 M	USA
Heska Corporation HSKA	137	-	-	$ 1.31 B	USA
Interpace Biosciences IDXG	29.1	$ 1.98	-2.37 %	$ 8.76 M	USA
Illumina ILMN	137	$ 127.88	1.95 %	$ 20.3 B	USA
Koninklijke Philips N.V. PHG	89	$ 27.47	-0.58 %	$ 20 B	Niderland
Personalis PSNL	12.1	$ 6.1	3.39 %	$ 361 M	USA
QIAGEN N.V. QGEN	141	-	-	$ 10.6 B	Niderland
Biomerica BMRA	147	$ 2.14	-0.47 %	$ 4.92 M	USA
ICON Public Limited Company ICLR	0.213	$ 102.17	-3.92 %	$ 8.43 B	Irlanda
Laboratory Corporation of America Holdings LH	18.9	$ 263.8	-0.43 %	$ 21.9 B	USA
Motus GI Holdings MOTS	3.37 K	-	-34.28 %	$ 263 K	Israel
Thermo Fisher Scientific TMO	86.5	$ 469.71	0.64 %	$ 177 B	USA
NeoGenomics NEO	24.4	$ 8.29	4.8 %	$ 1.06 B	USA
Neogen Corporation NEOG	147	$ 9.54	2.03 %	$ 2.07 B	USA
Twist Bioscience Corporation TWST	51.5	$ 60.94	3.55 %	$ 3.64 B	USA
Myriad Genetics MYGN	42.8	$ 4.78	-0.21 %	$ 443 M	USA
Natera NTRA	25.8	$ 203.75	1.3 %	$ 20.1 B	USA
Quest Diagnostics Incorporated DGX	9.34	$ 196.27	-1.66 %	$ 21.8 B	USA
Invitae Corporation NVTA	126	-	-	$ 21.2 M	USA
Organovo Holdings ONVO	371	-	-2.3 %	$ 19.4 M	USA
OpGen OPGN	459	-	-16.95 %	$ 1.54 M	USA
Waters Corporation WAT	528	$ 309.87	-0.43 %	$ 18.5 B	USA